Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedMar 14, 2025
DataAggregated Company Financials
Companies4
  • 7D-14.0%
  • 3M-29.9%
  • 1Y-42.4%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 14%, driven by pullbacks from every company within the industry. Overall the industry is down 38% in 12 months. Looking forward, earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 15 Mar 2025DKK 2.4tDKK 317.9bDKK 104.9b23.1x22.9x7.5x
Mon, 10 Feb 2025DKK 2.9tDKK 317.8bDKK 104.9b27.6x27.3x9x
Wed, 08 Jan 2025DKK 2.7tDKK 297.4bDKK 98.2b28.3x28x9.2x
Fri, 06 Dec 2024DKK 3.5tDKK 297.4bDKK 98.2b36x35.5x11.7x
Sun, 03 Nov 2024DKK 3.5tDKK 283.9bDKK 93.2b37.9x37.4x12.3x
Tue, 01 Oct 2024DKK 3.6tDKK 283.9bDKK 93.2b38.8x38.3x12.6x
Thu, 29 Aug 2024DKK 4.1tDKK 283.9bDKK 93.2b44.5x43.9x14.4x
Sat, 27 Jul 2024DKK 3.9tDKK 269.3bDKK 92.2b43.4x42.8x14.7x
Mon, 24 Jun 2024DKK 4.5tDKK 269.3bDKK 92.2b49.1x48.3x16.5x
Wed, 22 May 2024DKK 4.2tDKK 269.3bDKK 92.2b46.1x45.4x15.5x
Fri, 19 Apr 2024DKK 3.9tDKK 257.0bDKK 86.4b46x45.2x15.2x
Sun, 17 Mar 2024DKK 4.1tDKK 257.0bDKK 86.4b48.2x47.4x15.9x
Tue, 13 Feb 2024DKK 3.8tDKK 257.0bDKK 86.4b44.2x43.5x14.6x
Thu, 11 Jan 2024DKK 3.3tDKK 238.8bDKK 78.2b43.7x42.8x14x
Sat, 09 Dec 2023DKK 3.0tDKK 238.8bDKK 78.2b39.6x38.8x12.7x
Mon, 06 Nov 2023DKK 3.1tDKK 238.6bDKK 78.1b40.6x39.8x13x
Wed, 04 Oct 2023DKK 2.9tDKK 225.4bDKK 70.1b41.6x41.4x12.9x
Fri, 01 Sep 2023DKK 2.9tDKK 225.4bDKK 70.1b42.4x41.4x12.9x
Sun, 30 Jul 2023DKK 2.4tDKK 211.8bDKK 63.8b38.7x37.8x11.4x
Tue, 27 Jun 2023DKK 2.5tDKK 211.8bDKK 63.8b39.4x38.5x11.6x
Thu, 25 May 2023DKK 2.6tDKK 211.8bDKK 63.8b41.2x40.3x12.1x
Sat, 22 Apr 2023DKK 2.7tDKK 199.9bDKK 57.8b52.1x46.3x13.4x
Mon, 20 Mar 2023DKK 2.3tDKK 199.7bDKK 57.8b39.6x39x11.3x
Wed, 15 Feb 2023DKK 2.3tDKK 199.7bDKK 57.8b40.4x39.7x11.5x
Fri, 13 Jan 2023DKK 2.1tDKK 189.2bDKK 54.7b39.1x38.6x11.2x
Sun, 11 Dec 2022DKK 2.1tDKK 189.2bDKK 54.7b39.4x38.9x11.3x
Tue, 08 Nov 2022DKK 2.0tDKK 188.3bDKK 54.4b36.5x36.4x10.5x
Thu, 06 Oct 2022DKK 1.8tDKK 178.4bDKK 52.1b35.5x35.4x10.3x
Sat, 03 Sep 2022DKK 1.8tDKK 178.4bDKK 52.1b34.7x34.8x10.2x
Mon, 01 Aug 2022DKK 2.0tDKK 169.5bDKK 50.7b39.2x39.5x11.8x
Wed, 29 Jun 2022DKK 1.8tDKK 169.5bDKK 50.7b35.6x35.9x10.7x
Fri, 27 May 2022DKK 1.7tDKK 169.5bDKK 50.7b34x34.3x10.3x
Sun, 24 Apr 2022DKK 1.8tDKK 161.0bDKK 49.3b36.5x36.7x11.2x
Tue, 22 Mar 2022DKK 1.8tDKK 161.0bDKK 49.3b35.5x35.7x10.9x
Price to Earnings Ratio

35.7x


Total Market Cap: DKK 1.8tTotal Earnings: DKK 49.3bTotal Revenue: DKK 161.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 39.3x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 23.9x which is lower than its 3-year average PE of 39.3x.
  • The 3-year average PS ratio of 12.3x is higher than the industry's current PS ratio of 7.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 29% per year over the last three years.
  • Revenues for these companies have grown 25% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Danish Pharma compare with similar industries?

DK Market-8.47%
Healthcare-12.67%
Pharma-13.95%
Pharma-13.95%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
STENO StenocareDKK 0.443.3%
+DKK 279.7k
-92.6%PS4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.